Read More Pharma Industry News Aarti Drugs Q1 FY26 results: Can greenfield expansions and U.S. tariff shifts drive sustained margin growth? Aarti Drugs Q1 FY26 PAT jumps 62% YoY as greenfield expansions and U.S. tariff shifts open new export opportunities. Can margins sustain? byPallavi MadhirajuJuly 19, 2025